Glaucoma News

In recognition of World Glaucoma Week, March 7-13, Justin A. Schweitzer, OD, FAAO, spoke about the number of new options in the optometrist’s toolbox to diagnose and treat glaucoma to both catch the disease early and treat those affected.

Patients treated with Vyzulta for open-angle glaucoma and ocular hypertension had significantly better outcomes compared with most beta-blockers, according to results of a systemic review and network meta-analysis.

Three universities received funding from the CDC for their respective 5-year SIGHT studies investigating best practices to improve glaucoma screenings and intervention in vulnerable communities.

Researchers found that poorly fitted face masks can cause visual field artifacts that may be misinterpreted during standard automated perimetry as glaucoma progression or low test reliability.

Baseline features associated with blindness in children with primary congenital glaucoma showed that corneal clouding can predict future blindness, according to research published in the American Journal of Ophthalmology.

Since its birth, OCT revolutionized our ability to diagnosis and manage glaucoma. Fast forward to an extension of OCT, OCT angiography.

Most patients reported satisfaction with their glaucoma treatment despite a high frequency of ocular signs during ophthalmological exams and symptoms at and between instillations.

Low vitamin D is a potential risk factor for glaucoma, but further research is needed to determine the exact mechanism and evaluate the temporal and causal relationship.

A partnership between artificial intelligence systems and clinicians may lead to mutual advancements in glaucoma research and clinical practice, according to a review published in the British Journal of Ophthalmology.

Functional vision loss is predictive of retinal nerve fiber layer thinning in patients with glaucoma, according to a study published in Investigative Ophthalmology and Visual Science.